These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19195024)

  • 1. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.
    Ogane S; Onda T; Takano N; Yajima T; Uchiyama T; Shibahara T
    Int J Cancer; 2009 Jun; 124(11):2651-7. PubMed ID: 19195024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma.
    Onda T; Uzawa K; Endo Y; Bukawa H; Yokoe H; Shibahara T; Tanzawa H
    Br J Cancer; 2006 Mar; 94(5):698-709. PubMed ID: 16479256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer.
    Ma L; Dong S; Zhang P; Xu N; Yan H; Liu H; Li Y; Zhou Q
    Clin Lab; 2010; 56(9-10):407-16. PubMed ID: 21086786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of epigenetic inactivation of the human four and a half LIM domains 1 gene in human oral cancer.
    Koike K; Kasamatsu A; Iyoda M; Saito Y; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Tanzawa H; Uzawa K
    Int J Oncol; 2013 Jan; 42(1):141-50. PubMed ID: 23123766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
    Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
    Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer.
    Dong SW; Ma L; Xu N; Yan HQ; Liu HY; Li YW; Zhang P
    Neoplasma; 2011; 58(1):89-95. PubMed ID: 21067271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma.
    Uesugi H; Uzawa K; Kawasaki K; Shimada K; Moriya T; Tada A; Shiiba M; Tanzawa H
    Int J Mol Med; 2005 Apr; 15(4):597-602. PubMed ID: 15754020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of putative tumor suppressor gene spleen tyrosine kinase in esophageal squamous cell carcinoma.
    Dong SW; Zhang P; Zhong RR; Liu Q
    Clin Lab; 2013; 59(5-6):647-53. PubMed ID: 23865365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.
    Suzuki E; Imoto I; Pimkhaokham A; Nakagawa T; Kamata N; Kozaki KI; Amagasa T; Inazawa J
    Oncogene; 2007 Dec; 26(57):7921-32. PubMed ID: 17599052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of p300 in the tumor progression of oral squamous cell carcinoma.
    Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP
    J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma.
    Sakuma T; Uzawa K; Onda T; Shiiba M; Yokoe H; Shibahara T; Tanzawa H
    Int J Oncol; 2006 Jul; 29(1):117-24. PubMed ID: 16773191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
    Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
    Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of full-length spleen tyrosine kinase in the oral squamous cell carcinoma and its relationship with tumor invasion and metastasis].
    Wang Z; Chen J; Chu W; Da M; Ma L; Wu M; Zhong Y; Wang Z; Song X; Wu Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Oct; 33(5):519-23. PubMed ID: 26688948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
    Yuan Y; Mendez R; Sahin A; Dai JL
    Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.
    Luangdilok S; Box C; Patterson L; Court W; Harrington K; Pitkin L; Rhŷs-Evans P; O-charoenrat P; Eccles S
    Cancer Res; 2007 Aug; 67(16):7907-16. PubMed ID: 17699797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
    Zhang J; Ling T; Wu H; Wang K
    J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional repression of DLEC1 associates with the depth of tumor invasion in oral squamous cell carcinoma.
    Chan WH; Chang KP; Yang SW; Yao TC; Ko TY; Lee YS; Tsai CL; Tsai CN
    Oral Oncol; 2010 Dec; 46(12):874-9. PubMed ID: 20952247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and methylation status of the Syk gene in cervical carcinoma.
    Zhao S; Sun G; Tony PW; Ma D; Zhao C
    Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
    Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
    Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.